Siemens Healthineers to Invest $300M to Expand Dx Manufacturing, R&D in Massachusetts

Dec 14, 2016

|

NEW YORK (GenomeWeb) – Siemens Healthineers said today that it will invest $300 million to expand and upgrade its 500,000-sq. ft. laboratory diagnostics manufacturing and R&D facility in Walpole, Massachusetts, over the next four years.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Siemens Healthineers to Invest $300M to Expand Dx Manufacturing, R&D in Massachusetts

To read the full story....

Breaking News

FDA Authorizes Quest Diagnostics SARS-CoV-2/Flu Test With Self-Collection Kit for Emergency Use

Ravgen Sues Illumina, Roche Alleging Infringement of Cell-Free DNA Testing Patents

FDA Declines to Review EUA for Chembio Diagnostics SARS-CoV-2 Antibody Test

Sherlock Biosciences Licenses US Dx Rights to CRISPR-Cas12 From Tolo Biotech

FDA Authorizes Use of Pooled Samples With CDC Coronavirus Test

In Brief This Week: Agilent, Unilabs, Caris Life Sciences, and More

Featured White Papers

Case Study: Deployment of High-Throughput SARS-CoV-2 Testing at UC Davis

What's Popular?

FDA Declines to Review EUA for Chembio Diagnostics SARS-CoV-2 Antibody Test

Will US Ever Get to Mass Testing for COVID-19?

Testing of Asymptomatic Patients Moves Into Spotlight During Coronavirus Pandemic

FDA Authorizes Use of Pooled Samples With CDC Coronavirus Test

FDA Warns Lab Company to Stop Sale of Unauthorized SARS-CoV-2 Collection Kit

Sponsorships